Researchers have designed a limb girdle muscular dystrophy 2A gene therapy preventing cardiotoxicity of...
Up To Date
Latest News
Having secured a €2.785m grant from the EU and €4.55m from a Series B round, MaxiVAX is going full steam...
Geneva-based GeNeuro SA announced a new clinical study of temelimab to treat patients with multiple sclerosis...
Roche AG said on Friday that its PD-L1 blocker Tecentriq plus its VEFG blocker Avastin improved...
Azeria Therapeutics Ltd (Cambridge, UK) has raised a £32m (€37.3m) in a Series B financing led by Syncona Ltd ...
GHO Capital raises €975m in largest ever European private equity healthcare fund.